Dose Escalation of Lenalidomide in Relapsed or Refractory Acute Leukemias

PURPOSE: Lenalidomide is effective in myeloma and low-risk myelodysplastic syndromes with deletion 5q. We report results of a phase I dose-escalation trial of lenalidomide in relapsed or refractory acute leukemia. PATIENTS AND METHODS: Thirty-one adults with acute myeloid leukemia (AML) and four adu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Blum, William, Klisovic, Rebecca B., Becker, Heiko, Yang, Xiaoxia, Rozewski, Darlene M., Phelps, Mitch A., Garzon, Ramiro, Walker, Alison, Chandler, Jason C., Whitman, Susan P., Curfman, John, Liu, Shujun, Schaaf, Larry, Mickle, Jon, Kefauver, Cheryl, Devine, Steven M., Grever, Michael R., Marcucci, Guido, Byrd, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020696/
https://ncbi.nlm.nih.gov/pubmed/20956622
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3339
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados